Concepedia

Publication | Closed Access

Phase 1 Study of ABT-751, a Novel Microtubule Inhibitor, in Patients with Refractory Hematologic Malignancies

DOI

79

Citations

51

References

2005

Year

Karen Yee, A. Hagey, Srđan Verstovšek, Jörge E. Cortes, Guillermo Garcia‐Manero, Susan O’Brien, Stefan Faderl, Deborah A. Thomas, William G. Wierda, Steven M. Kornblau,
Clinical Cancer Research

Abstract

Further assessment of ABT-751, especially in combination with other agents, in patients with acute leukemias is warranted.

References

YearCitations

Page 1